Royce & Associates LP Amphastar Pharmaceuticals, Inc. Transaction History
Royce & Associates LP
- $10.5 Billion
- Q3 2024
A detailed history of Royce & Associates LP transactions in Amphastar Pharmaceuticals, Inc. stock. As of the latest transaction made, Royce & Associates LP holds 9,076 shares of AMPH stock, worth $330,547. This represents 0.0% of its overall portfolio holdings.
Number of Shares
9,076
Previous 9,076
-0.0%
Holding current value
$330,547
Previous $363,000
21.21%
% of portfolio
0.0%
Previous 0.0%
Shares
5 transactions
Others Institutions Holding AMPH
# of Institutions
280Shares Held
36.5MCall Options Held
74.3KPut Options Held
22.3K-
Black Rock Inc. New York, NY5.94MShares$216 Million0.01% of portfolio
-
Vanguard Group Inc Valley Forge, PA2.71MShares$98.8 Million0.0% of portfolio
-
Td Asset Management Inc2.14MShares$77.8 Million0.1% of portfolio
-
Federated Hermes, Inc. Pittsburgh, PA1.95MShares$70.9 Million0.22% of portfolio
-
Neuberger Berman Group LLC New York, NY1.62MShares$58.8 Million0.06% of portfolio
About Amphastar Pharmaceuticals, Inc.
- Ticker AMPH
- Exchange NASDAQ
- Sector Healthcare
- Industry Drug Manufacturers—Specialty & Generic
- Shares Outstandng 49,015,200
- Market Cap $1.79B
- Description
- Amphastar Pharmaceuticals, Inc., a bio-pharmaceutical company, develops, manufactures, markets, and sells generic and proprietary injectable, inhalation, and intranasal products in the United States, China, and France. The company operates through two segments, Finished Pharmaceutical Products and API. It offers Primatene Mist, an over-the-count...